Editorial

Osterhaus, A. D. M. E.; Vanlangendonck, Chris

doi:10.1016/j.vaccine.2009.08.015

Cited by 3 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Forty‐five articles (full text or abstracts, as indicated in the references) were considered relevant for the recommendations 23, 24, 25, 26, 27, 28, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84. Additionally, EU reviews of the communication about 2009/10 (H1N1) pandemic influenza vaccines 22, 85 and key publications on medicines/vaccines communication were extracted 9, 21, 86, 87, 88, 89.…”

Section: Search Strategymentioning

confidence: 99%

Listen to the public and fulfil their information interests – translating vaccine communication research findings into guidance for regulators

Bahri¹,

Melero²

2018

Brit J Clinical Pharma

View full text Add to dashboard Cite

Regulatory authorities have a crucial role in communicating about the vaccines they license. In terms of content and timing, their communication to the public is usually driven by data on quality, safety and efficacy. However, concerns over safety and vaccine hesitancy have emerged in some communities in various countries, and this demands a new approach to communication, starting with listening to the public debate. Reviewing communication research findings, coming in particular from the cognitive, decision‐making and media sciences, constitutes one mechanism of listening and has led the European Union (EU) regulatory network to developing guidance about which common concerns and information needs of the public to address through proactive and prepared communication. The guidance has been welcomed by EU and international fora. The current article summarizes the recommendations and shares the underlying research findings, as well as a proof of concept that communication research can be valuable for regulators. It is critical that regulators integrate the communication process with product risk assessment in the framework of pharmacovigilance, to ensure that public concerns are addressed in the assessments and that information about evidence and uncertainty relating to safety is provided to the public and vaccination policy makers in a specific, clear and accurate manner. Additionally, information from regulatory authorities should support healthcare professionals in their communication with patients. Meeting the information interests of the public is the principal prerequisite for informed decisions as well as safe and effective use of vaccines and medicines overall. This is also fundamental for trust in the authorities' commitment to patient and population health.

show abstract

Section: Search Strategymentioning

confidence: 99%

Listen to the public and fulfil their information interests – translating vaccine communication research findings into guidance for regulators

Bahri¹,

Melero²

2018

Brit J Clinical Pharma

View full text Add to dashboard Cite

show abstract

Publics and Vaccinomics: Beyond Public Understanding of Science

Einsiedel

2011

OMICS: A Journal of Integrative Biology

View full text Add to dashboard Cite

Vaccines have been among the most effective tools for addressing global public health challenges. With the advent of genomics, novel approaches for vaccine discovery are opening up new opportunities for vaccine development and applications, particularly with the expectation of personalized vaccines and the possibility of addressing a broader range of infectious diseases. In this context, it is useful to reflect on the social contexts of vaccine development as these have been influenced by social, ethical, political challenges. This article discusses the historical context of vaccine controversies and factors that help explain public acceptance and resistance, illustrating that these challenges go well beyond simple public misunderstandings. The broader vaccine challenges evident along the innovation trajectory, from development to commercialization and implementation include problems in research and development, organizational issues, and legal and regulatory challenges that may collectively contribute to public resistance or confidence. The recent history of genomics provides further lessons that the developing field of vaccinomics can learn from.

show abstract

Framing Pandemic Management: New Governance, Science or Culture?

Carney

Bennett

2014

Health Sociology Review

View full text Add to dashboard Cite

Editorial

Cited by 3 publications

References 0 publications

Listen to the public and fulfil their information interests – translating vaccine communication research findings into guidance for regulators

Listen to the public and fulfil their information interests – translating vaccine communication research findings into guidance for regulators

Publics and Vaccinomics: Beyond Public Understanding of Science

Framing Pandemic Management: New Governance, Science or Culture?

Contact Info

Product

Resources

About